Orchid Pharma Q2 Results
- BSE: 524372
- NSE: ORCHPHARMA
- ISIN: INE191A01027
- Sector: Biotechnology & Drugs
BSE
1,508.25
49.15 (3.37%)
49.15 (3.37%)Volume16.46 K
Updated: Mon 25 Nov, 2024 | 15:55:26
NSE
1,510.5552.20 (3.58%)
52.20 (3.58%)Volume96.54 K
Updated: Mon 25 Nov, 2024 | 15:29:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹222.70 Cr.(-8.88%)
- Operating Profit₹21.71 Cr.(-9.71%)
- Profit After Tax₹27.24 Cr.(-7.20%)
- Operating Margin9.75%(25.24%)
Note: Comparison is on YoY basis
Quarterly - Orchid Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 222.70 | 182.92 | -% | 198.76 | -% |
| Selling/ General/ Admin Expenses Total | 20.06 | 16.22 | -% | 17.56 | -% |
| Depreciation/ Amortization | 8.63 | 7.71 | -% | 7.84 | -% |
| Other Operating Expenses Total | 41.14 | 32.49 | -% | 35.55 | -% |
| Total Operating Expense | 200.99 | 168.48 | -% | 183.28 | -% |
| Operating Income | 21.71 | 14.43 | -% | 15.47 | -% |
| Net Income Before Taxes | 25.90 | 10.78 | -% | 20.02 | -% |
| Net Income | 27.24 | 9.40 | -% | 19.80 | -% |
| Diluted Normalized EPS | 5.37 | 1.85 | -% | 4.30 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST